Lorcaserin and Behavioral Modification for Overweight and Obesity Management in Chinese Obese Patients
Status:
Suspended
Trial end date:
2021-07-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and weight loss effect of lorcaserin at the
end of the first year of treatment (Week 48) in overweight and Chinese adult obese patients
compared to placebo.